News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Ana Sandoval

Articles by Ana Sandoval

42 Exploring the Treatment Gap in High-Risk HR+, HER2– Early Breast Cancer: Eligible Patients Not Receiving Abemaciclib in the US

ByAna Sandoval,Joyce A. O’Shaughnessy,Astra M. Liepa,Brenda Grimes,Katheryn Moreira,James Roose,Catherine Keane,Sara M. Tolaney, MD, MPH

May 29th 2025

Latest Updated Articles

Trending on CancerNetwork

FDA Approves T-DXd Plus Pertuzumab in Metastatic HER2+ Breast Cancer

FDA Grants National Priority Voucher to Teclistamab/Daratumumab in RRMM

Omitting Sentinel Lymph Node Biopsy Is Safe in Select Patients With HR+ Early Breast Cancer

The Challenge of Making Bispecifics More Accessible in R/R Multiple Myeloma

How Might CTO1681 Prevent CRS After CAR T-Cell Therapy in DLBCL?

© 2025 MJH Life Sciences^®

All rights reserved.